Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.1 CHF | -1.44% | -0.96% | -3.86% |
Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Business Summary
Number of employees: 10
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -57.97% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -57.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - | ||
Felicia Flanigan
PRN | Corporate Officer/Principal | - | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 | |
Director/Board Member | 66 | 22-03-16 | |
Laura Hamill
BRD | Director/Board Member | 60 | 22-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,400,000 | 53,870,953 ( 97.24 %) | 554,000 ( 1.000 %) | 97.24 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
8,590,000 | 5.89% | 359,405,600 $ | |
SAGE THERAPEUTICS, INC. 5.83% | 3,505,000 | 5.83% | 47,597,900 $ |
BB BIOTECH AG 1.00% | 554,000 | 1.00% | 24,977,267 $ |
ANNEXON, INC. 4.46% | 4,682,290 | 4.46% | 21,491,711 $ |
WAVE LIFE SCIENCES LTD. 3.68% | 4,494,458 | 3.68% | 21,303,731 $ |
MOLECULAR TEMPLATES, INC. 23.81% | 1,279,820 | 23.81% | 2,047,712 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Biotech Invest NV
| |
Biotech Focus NV
| |
Biotech Growth NV
Biotech Growth NV Financial ConglomeratesFinance Part of BB Biotech AG, Biotech Growth NV is a Dutch company that provides blank check company services. The company is located in the Netherlands. |
Financial Conglomerates
|
Biotech Target NV
Biotech Target NV MiscellaneousMiscellaneous Part of BB Biotech AG, Biotech Target NV is a Dutch company that specializes in the offices of other holding companies. The company is located in the Netherlands. |
Miscellaneous
|
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.86% | 2.51B | |
+41.79% | 54.04B | |
+47.19% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- BION Stock
- Company BB Biotech AG